ANNX (ANNX) Stock Price & Analysis
ANNX (ANNX) rose 0.00% to USD 5.22 as of July 25, 2026 at 03:38 UTC, according to Nexqual real-time market data.
ANNX last closed at USD 5.22; the session ranged USD 5.16–5.61 on volume of 2,680,229 shares. Market capitalization is —, with a 52-week range of USD 2.03–7.18 (NMS). Source: Nexqual, July 25, 2026 at 03:38 UTC.
Key Statistics (as of July 25, 2026 at 03:38 UTC)
| Price | USD 5.22 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 5.22 |
| Open | USD 5.22 |
| Day Range | USD 5.16 – 5.61 |
| 52-Week Range | USD 2.03 – 7.18 |
| Volume | 2,680,229 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ANNX)
Nexqual's technical model rates ANNX "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:38 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.02 (neutral) |
| vs SMA50 | Below (USD 5.37) |
| MACD | -0 (negative) |
From ANNX's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc. | USD 2.03 | ▲ 0.5% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 10.07 | ▼ 8.12% |
| NKTX | Nkarta, Inc. | USD 2.27 | ▼ 5.81% |
| HOWL | Werewolf Therapeutics, Inc. | USD 0.43 | ▲ 16.99% |
| CCCC | C4 Therapeutics, Inc. | USD 3.4 | ▼ 9.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:38 UTC. This page is informational and not investment advice.